Continued destocking by customers following the Corona pandemic and generally weak demand are weighing more heavily on Sartorius than previously thought. The pharmaceutical and laboratory equipment. | June 17, 2023
CHK-336 was generally well tolerated in healthy volunteers who received single doses up to 500 mg and multiple doses up to 60 mg for 14 daysPharmacokinetics was well characterized with. | June 17, 2023
Study did not meet the primary endpointPamrevlumab was generally safe and well tolerated Topline results from LELANTOS-2 Phase 3 study of pamrevlumab in ambulatory patients with DMD expected 3Q 2023 . | June 7, 2023
- CYT-0851 has demonstrated early activity in combination with capecitabine or gemcitabine in advanced solid tumors and a generally well tolerated safety profile in a heavily pretreated population of. | June 3, 2023